← Home
© 2024 - 2025 InsightfulValue.com. All rights reserved.
Press Releases
Date | Press release |
---|---|
2025-04-29 16:05:00 | Gilead Sciences To Present At Upcoming Investor Conferences Foster city, calif.--(business wire)-- #gild--gilead sciences, inc. (nasdaq: gild) announced today that its executives will be speaking at the following investor conferences: bofa securities health care conference on tuesday, may 13 at 11:20 am pacific time rbc capital markets global healthcare conference on wednesday, may 21 at 11:30 am eastern time bernstein annual strategic decisions conference on thursday, may 29 at 2:30 pm eastern time jefferies global healthcare conference on wednesday, june 4 at. |
2025-04-29 08:30:00 | Gilead To Present Latest Advancements Across Primary Biliary Cholangitis And Viral Hepatitis Foster city, calif.--(business wire)--gilead sciences, inc. (nasdaq:gild) today announced new research to be presented at the european association for the study of the liver (easl) congress, may 7-10, 2025, amsterdam, furthering gilead’s commitment to transform the lives of people living with liver disease. new data to be presented at easl will include a subgroup analysis from assure, an ongoing open-label study, and an analysis of the phase 3 response trial and the open-label extension. data w. |
2025-04-24 16:02:00 | Gilead Sciences Announces First Quarter 2025 Financial Results Foster city, calif.--(business wire)-- #earnings--gilead sciences, inc. (nasdaq: gild) announced today its first quarter 2025 results of operations. “gilead had a strong start to the year driven by excellent commercial and clinical execution along with disciplined expense management,” said daniel o’day, gilead’s chairman and chief executive officer. “our base business grew 4% year-over-year, primarily led by biktarvy’s continued strength, and we announced positive topline phase 3 results for trodelvy plus. |
2025-04-10 16:05:00 | Gilead Sciences To Release First Quarter 2025 Financial Results On Thursday, April 24, 2025 Foster city, calif.--(business wire)-- #earnings--gilead sciences, inc. (nasdaq: gild) announced today that its first quarter 2025 financial results and guidance will be released on thursday, april 24, 2025 after the market closes. at 4:30 p.m. eastern time that day, gilead’s management will host a webcast to discuss the company’s first quarter 2025 financial results and provide a business update. a live webcast will be available in the investors section of www.gilead.com and will be archived there for one. |
2025-03-12 08:30:00 | Gilead Presents New Hiv Treatment And Cure Research Data At Croi 2025, Including An Investigational Long-acting, Twice-yearly Therapy Option Foster city, calif.--(business wire)--gilead sciences, inc. (nasdaq: gild) today announced the presentation of late-breaking data and multiple oral presentations from its innovative hiv treatment portfolio and pipeline at the conference on retroviruses and opportunistic infections (croi 2025). the new findings reflect a transformative portfolio and a rapidly advancing forward-looking pipeline focused on expanding choices and enhancing outcomes for those with hiv, while continuing to reach towar. |
2025-03-11 13:37:00 |
|
2025-02-24 08:30:00 |
|
2025-02-20 16:30:00 |
|
2025-02-19 16:05:00 |
|
2025-02-18 08:30:00 |
|
2025-02-11 16:05:00 |
|
2025-02-11 16:02:00 |
|
2025-02-07 12:56:00 |
|
2025-01-30 08:00:00 |
|
2025-01-11 11:00:00 |
|
